Matthew L. Posard - 05 May 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
Director
Signature
/s/ James R. Oehler as attorney-in-fact for Matthew L. Posard
Issuer symbol
HALO
Transactions as of
05 May 2022
Transactions value $
$0
Form type
4
Filing time
06 May 2022, 20:07:58
Previous filing
01 Dec 2021
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Restricted Stock Units Award $0 +6.21K +4.81% $0.00 135K 05 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2023 and (ii) the date of the Issuer's next annual meeting of stockholders.